ETF Plays for a Divided Midterm Elections
With a contentious midterms election season coming up, many anticipate a split government that could potentially impact the way ETF investors ride…
Pharmaceuticals
Pharmaceutical ETFs Could Maintain Their Momentum
Pharmaceutical stocks and sector-related exchange traded funds have enjoyed a great summer and the rally may continue to have legs. Over the…
Loncar Debuts ETF to Play China’s Biotech, Pharma Companies
Loncar Investments has partnered up with Exchange Traded Concepts to launch a new ETF that tracks the growing biopharmaceutical sector in China.…
Biotech ETFs Rally as Illumina Tops Q2 Expectations
Biotechnology sector ETFs were among the best performers Tuesday, with Illumina (NasdaqGS: ILMN) shares surging after the genomics firm beat second-quarter expectations…
July Could Be a Volatile Month for Pharma ETFs
Changing political winds and the seasonal period for drugmakers to hike their prices could trigger short-term volatility in pharmaceutical sector-related ETFs. The…
Amazon ETFs Mostly Down After PillPack Acquisition
Online retailer Amazon is ready to shake up the drugstore market as the company announced it would acquire online pharmacy PillPack. ETFs…
6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign…
Direxion Resuscitates Leveraged Pharmaceutical ETF
Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion…
Biotech, Pharma ETFs Leave Pricing Drama Behind
Biotechnology and pharmaceutical ETFs have rallied in recent weeks as drug pricing concerns wane and investors look to the opportunity of this…
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Alternative ETF Options to Hedge Trump Risk on Obamacare
After Republicans unveiled their Obamacare replacement, healthcare and biotechnology-related sectors were none too pleased. Nevertheless, exchange traded fund investors can still hedge…
Healthcare ETFs Are Latest Victim to Trump
Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug…
Rising Rates May Hurt Small-Cap Biotech ETF Valuations
The Federal Reserve has hiked interest rates for the second time in a decade and plans to raise rates three more times…
Trump Bursts Biotech ETFs’ Bubble
Biotechnology stocks and sector-related exchange traded funds retreated Tuesday after President-elect Donald Trump vowed to “bring down drug prices.” The iShares Nasdaq…